Lemborexant

Dayvigo

5 MG TabletCanadaMarketedAuthorised 6 Nov 2020

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

DayvigoBrazil · Eisai Laboratórios LtdaSame brand
Dayvigo Film-Coated Tablet 10MGSingapore · 10 mg · tablet, film coated · Eisai (Singapore) Pte. LTD.Same brand
Dayvigo Film-Coated Tablet 5MGSingapore · 5 mg · tablet, film coated · Eisai (Singapore) Pte. LTD.Same brand
DayvigoUnited States · 10MG, 5MG · tablet · Eisai INCSame brand

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lemborexant

Dayvigo

5 MG TabletCanadaMarketedAuthorised 6 Nov 2020

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lemborexant
Strength: 5 MG
Dosage form: Tablet
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 6 Nov 2020
Registration: DIN 02507366
Marketing authorisation holder: Eisai Limited
ATC code: N05CJ02
Group: Nervous system
Supply: PRESCRIPTION